Neuralink has raised $1.29 billion in total funding across multiple rounds, including Series E ($650M, May 2025), Series D ($323M + $43M, 2023), and Series C ($205M, 2021). Backed by top investors such as Founders Fund, Google Ventures, Sequoia Capital, and ARK Investment Management, the company reached a $5 billion valuation as of June 2023. Founded in 2016, Neuralink continues to attract capital to advance its implantable brain-computer interfaces, accelerating its mission to revolutionize human–machine interaction and restore lost neurological functions.